Here ’s What Americans Think of Weight Loss Drugs

Not every major medical innovation breaks through to the general public. But the buzzy weight loss drugs for people with obesity or Type 2 diabetes certainly have. About 75% of Americans have heard of Ozempic, Wegovy and other brands of anti-obesity drugs, according to the results of a new Pew Research Center survey. (Wegovy and Zepbound are specifically approved to treat obesity, while Ozempic and Mounjaro are approved to treat people with Type 2 diabetes and can help them lose weight.) [time-brightcove not-tgx=”true”] The survey included more than 10,000 people of different ages, genders, races, ethnicities, education levels and political affiliations who were randomly recruited to answer online questions about obesity and the new class of anti-obesity medications. Among those familiar with the drugs, 53% said they were good weight-loss options for people with obesity, while 28% were unsure—and 62% said they were not good options for people without a weight-related health condition. That last stat reflects the controversial, widely publicized trend of people without these conditions taking the drugs as a quick way to lose weight. Read More: More Weight Loss Drugs Are Coming, and They Could Be Even More Effective When asked what impact the drugs would have on reducing obesity in America, 35% thought they would do “not much” or “nothing at all,” and only 16% thought the medications would do “a great deal” ...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized healthscienceclimate Source Type: news